Page last updated: 2024-10-27

fluoxetine and Apnea

fluoxetine has been researched along with Apnea in 4 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
" We present a patient whose severe hyperventilation and apneic attacks resolved with the concomitant treatment of fluoxetine and buspirone."7.78Use of buspirone and fluoxetine for breathing problems in Rett syndrome. ( Ardıç, UA; Gökben, S; Serdaroğlu, G, 2012)
"To describe a patient who developed serotonin syndrome on four separate occasions as a result of monotherapy with two different selective serotonin receptor inhibitors (fluoxetine and cetalopram)."7.71Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy. ( Chechani, V, 2002)
" We present a patient whose severe hyperventilation and apneic attacks resolved with the concomitant treatment of fluoxetine and buspirone."3.78Use of buspirone and fluoxetine for breathing problems in Rett syndrome. ( Ardıç, UA; Gökben, S; Serdaroğlu, G, 2012)
"To describe a patient who developed serotonin syndrome on four separate occasions as a result of monotherapy with two different selective serotonin receptor inhibitors (fluoxetine and cetalopram)."3.71Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy. ( Chechani, V, 2002)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gökben, S1
Ardıç, UA1
Serdaroğlu, G1
Walsh, M1
Knilans, TK1
Anderson, JB1
Czosek, RJ1
Chechani, V1
Kopelman, PG1
Elliott, MW1
Simonds, A1
Cramer, D1
Ward, S1
Wedzicha, JA1

Trials

1 trial available for fluoxetine and Apnea

ArticleYear
Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1992, Volume: 16, Issue:10

    Topics: Adult; Apnea; Double-Blind Method; Female; Fluoxetine; Humans; Hypoventilation; Male; Middle Aged; O

1992

Other Studies

3 other studies available for fluoxetine and Apnea

ArticleYear
Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
    Pediatric neurology, 2012, Volume: 46, Issue:3

    Topics: Apnea; Buspirone; Child; Female; Fluoxetine; Humans; Hyperventilation; Rett Syndrome; Selective Sero

2012
Successful treatment of pallid breath-holding spells with fluoxetine.
    Pediatrics, 2012, Volume: 130, Issue:3

    Topics: Apnea; Electrocardiography; Female; Fluoxetine; Humans; Infant; Male; Pacemaker, Artificial; Selecti

2012
Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy.
    Critical care medicine, 2002, Volume: 30, Issue:2

    Topics: Adult; Apnea; Coma; Female; Fluoxetine; Humans; Serotonin Receptor Agonists; Serotonin Syndrome

2002